¶ÈÀÓ¾Ò²ð

2001ǯ

¸¶ÃøÏÀʸ¡¿¾ÉÎãÊó¹ð

  1. Nobuhara K, Farde L, Halldin C, Karlsson P, Swahn CG,Olsson H, Bergstrom KA, Larsson SA, Schnell PO, McPherson DW, Savonen A, Hiltunen J, Sedvall G ;
    SPECT imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP¡¥E J Nucl Med 28 (1)13-24
  2. Isotani T, Tanaka H, Lehmann D, Pascual-Marqui RD, Kochi K, Saito N, Yagyu T, Kinoshita T ,Sasada K ; Source localization of EEG activity during hypnotically induced anxiety and relaxation¡¥Int J Psychophysiol 41 143-153
  3. Isotani T, Lehmann D, Pascual-Marqui RD, Kochi K, Wackermann J, Saito N, Yagyu T, Kinoshita T,Sasada K ; EEG source localization and global dimensional complexity in high-and low- hypnotizable subjects: A pilot study¡¥Neuropsychobiol 44:192-198
  4. Lehmann D, Faber PL, Isotani T ,Wohlgemuth P ; Source locations of EEG frequency bands during hypnotic arm levitation: A pilot study¡¥Contemporary Hypnosis 18:120-127
  5. Hirota T, Yagyu T ,Pascual-Marqui RD, Saito N, Kinoshita T ; Spatial Structure of Brain Electric Fields during Intermittent Photic Stimulation¡¥Neuropsychobiology 44:108-112
  6. Yamane H, Kinoshita T ; An Interactional Model of Mental Disability(IMMD)Based on the International¡¥Classification of Functioning and Disability(ICIDH-2)
    Asian J Occup Ther1 1-11
  7. °ëë½ÓÌÀ¡¤ºûÅĶ¯Ê¼¡¤ã·Æ£Ä¾Ì¦¡¤ÌøÀ¸Î´»ë¡¤Ä¥³¤Î衤ÌÚ²¼Íøɧ ; ºÅ̲´¶¼õÀ­¤Î°ã¤¤¤Ë¤è¤ê¶õ´ÖŪǾÅŰ̳èÆ°¤Ëº¹°Û¤Ï¤¢¤ë¤«¡¥ºÅ̲¤È²Ê³Ø 16:30-37
  8. ±ÊÅľ»¹°¡¤µÈ¼¶©»Ë¡¤ µÜÅÄ·ÃÈþ»Ò¡¤±ÛÃÒͧ»Ò¡¤ÌÚ²¼Íøɧ ; ´ØÀ¾°å²ÊÂç³ØÉí°É±¡¤Ë¤ª¤±¤ëfluvoxamine¤Î½èÊýÆ°¸þ¡¥¶¯Ç÷À­¾ã³²¤Î¸¦µæ2:1-6
  9. Æþß· ÁÌÚ²¼Íøɧ ; ÈóÄê·¿¹³Àº¿ÀÉÂÌô¤Î»È¤¤Ê¬¤±¡¥Î×¾²Àº¿ÀÌôÍý4 :1625- 1631
  10. ¿ùËÜãºÈ¡¤ã·Æ£¼ë¼Â¡¤¶Ì³ÀÀé½Õ¡¤ ÌøÀ¸Î´»ë¡¤±ä¸¶·òÆó¡¤ÌÚ²¼Íøɧ ; ¥¾¥Ë¥µ¥ß¥É¤Ë¤è¤ë¥¢¥·¥Ç¥ß¥¢¤È´ØÏ¢¤¹¤ë¤È»×¤ï¤ì¤ëÉûºîÍѤòÄ褷¤¿1¾ÉÎã¤È¥¾¥Ë¥µ¥ß¥É¤ÎÍ­¸ú·ìÃæÇ»Å٤ȿïȼ¾É¾õ¤Î¸¦µæ¡¥Âçºå¤Æ¤ó¤«¤ó¸¦µæ²ñ»¨»ï 12 (1)19-22
  11. Ê¡ÅçÀµ¿Í¡¤ÌÚ²¼Íøɧ¡¤»°²È±ÑÌÀ ; Àº¿À²ÊÎΰè¤Ë¤ª¤±¤ë¶î¤ª·ìºÞ¤Î»ÈÍѷи³ ¿À·Ð¾É·÷¤Î½÷À­Îã¤Ë¤Ä¤¤¤Æ¡¥ÆüËÜÅìÍο´¿È°å³Ø¸¦µæ15(1)57-58
  12. ËѾáÍö¡¤ºØƣľ̦¡¤ ÌøÀ¸Î´»ë¡¤ Ê¿°æ¥¿¥«¥Í¡¤ ÌÚ²¼Íøɧ ; ¥µ¥ë¥×¥êÉñÍÙ¥¤¥á¡¼¥¸»þ¤ÎÀº¿À³èÆ°¤ÈǾÇÈÊѲ½¡¥ºÅ̲¤È²Ê³Ø 16(1)43-48

¥Ú¡¼¥¸TOP¤ØÌá¤ë

ÁíÀ⡦²òÀâ

  1. ÌÚ²¼Íøɧ¡¤ÉðÅIJí½Ó¡¤±ÛÌʸ¡¤´ßËÜǯ»Ë ; ÈóÄê·¿¹³Àº¿ÀÉÂÌô¤Ë¤è¤ëʬÎöɤÎĹ´ü´Ö´ÉÍý¡¥Pharma Medica 19:85-95

¥Ú¡¼¥¸TOP¤ØÌá¤ë

Ãø½ñ

  1. ÌÚ²¼Íøɧ ; ¾É¾õ¤«¤é¿ÇÃÇ¤Ø Âè4½¸9.¹ÔÆ°°Û¾ï¡¥ÆüËÜ°å»Õ²ñ»¨»ï125(8)50-55
  2. ¿¥ÅÄ͵¹Ô¡¤ÌÚ²¼Íøɧ ; ½ªËö´ü´Î´â´µ¼Ô¤Î¥³¥ó¥µ¥ë¥Æ¡¼¥·¥ç¥ó¡¥¤³¤³¤í¤ÎÎ×¾² ¤Û¤ó¤È¤¦¤Ëº¤¤Ã¤¿¾ÉÎ㽸¡§Àº¿À²ÊÊÔ Âè20´¬27-29 À±Ï½ñŹ
  3. ÌÚ²¼Íøɧ ; º¤Æñ¤Ê¾ÉÎ㤫¤é³Ø¤ÖÂè5²ó¡ÖÉѲó¤ÎÅŵ¤¥·¥ç¥Ã¥¯ÎÅË¡¤òÍפ¹¤ë¶ÛĥɾõÂÖ¤òÄ褷¡¢³°Íè¼£ÎŤ¬º¤Æñ¤Ê°ìÎã¡×¡¥COMMENT Schizophrenia Frontier 2(4):55¥á¥Ç¥£¥«¥ë¥Ó¥å¡¼
  4. ÌÚ²¼Íøɧ¡¤¿¥ÅÄ͵¹Ô ; ¤À¤ë¤µ¤òÁʤ¨¡¢¸¡ºº¤ÇÆä˰۾郎¤ß¤Ä¤«¤é¤Ê¤¤´µ¼Ô¤ò¤ß¤¿¤é
    ¿ÇÃǤȼ£ÎÅÁý´©¹æ89 P453°ìÈÌ°å¤Î¤¿¤á¤Î³°Íè¿ÇÎŤΥҥó¥È ¿ÇÃǤȼ£ÎżÒ
  5. R.D.Pasqual-Marqui(ÌÚ²¼Íøɧ¡¤°ëë½ÓÌÀ¡¤±ä¸¶·òÆó¡¤ÌøÀ¸Î´»ë¡¤×¢ÅÄÂîÌéÌõ)
    Chapter4 ÅŸ»¿äÄꡧÁж˻Ҥ«¤éLORETA¤Þ¤Ç¡¥ÌôʪǾÇȳؤοÊÊâ 61-70 À±Ï½ñŹ
  6. D.Lehaman(ÌÚ²¼Íøɧ¡¤°ëë½ÓÌÀ¡¤±ä¸¶·òÆó¡¤ÌøÀ¸Î´»ë¡¤Æþß· ÁïÌõ)Chapter5 ³Ñ¼þÇÈ¿ôÂÓ°è¤Ë¤ª¤±¤ëÅÅ°ÌȯÀ¸¸»¶Éºß¿¼µá¤Î¸¶Íý¡§FFTÁж˻Ҷá»÷Ë¡¤È¤½¤Î±þÍÑ
    ÌôʪǾÇȳؤοÊÊâ 71-81 À±Ï½ñŹ
  7. W.M.Hermann(ÌÚ²¼Íøɧ¡¤°ëë½ÓÌÀ¡¤±ä¸¶·òÆó¡¤ÌøÀ¸Î´»ë¡¤¿ù»³Í´É×Ìõ)Chapter8 Î×¾²ÌôÍý»î¸³¤Ë¤ª¤±¤ë¸þÀº¿ÀÌô¤ÎʬÎà¡¥ÌôʪǾÇȳؤοÊÊâ 111-136 À±Ï½ñŹ

¥Ú¡¼¥¸TOP¤ØÌá¤ë

2000ǯ

¸¶ÃøÏÀʸ¡¿¾ÉÎãÊó¹ð

  1. Nobuhara K, Halldin C, Hall H, et.al. ; Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease¡¥ Psychopharmacology149 45-55
  2. Tamagaki C,Murata A, Asai S, Takase K, Gonnno K,Sakata T , Kinoshita T ; Age-related changes of cornu ammonis 1 pyramidal neurons in gerbil transient ischemia .Neuropathology20:221-227
  3. ¹âÀ¥¾¡¶µ¡¤Â­Î©Ì÷¡¤°Â¿åÎÉÃΡ¤ÅÚ´ô½ã»Ò¡¤¶âÅ´Æ²¬Â¼ÌÀ¼£¡¤¼ã¾¾ÀµÇ·¡¤¾®ÌøÄż£¼ù¡¤²Ã¸ÍÌ÷¡¤°æ¾å¶³°ì¡¤ÌÚ²¼Íøɧ¡¤ÃÓ¸¶¿Ê ; ´Îž°Ü¤Çȯ¸«¤µ¤ì,¿ºÌ¤Ê¼ðáç¥Þ¡¼¥«¡¼¤ò¼¨¤·¤¿¶»Á£´â¤Î1˶¸¡Îã¡¥¶»Éô³°²Ê53(6)450-455
  4. ã·Æ£Àµ¸Ê¡¤ÌÚ²¼Íøɧ¡¤ÅÏÊÕ¾»Í´ ; ÁªÂòŪ¥»¥í¥È¥Ë¥óºÆ¼è¤ê¹þ¤ßÁ˳²Ìô±ö»À¥Ñ¥í¥­¥»¥Á¥ó¤Î¤¦¤ÄɵڤӤ¦¤Ä¾õÂÖ¤ËÂФ¹¤ëĹ´üÅêÍ¿»î¸³¡¥ÌôÍý¤È¼£ÎÅ28´¬Suppl.1 S211-S223
  5. ¶Ì³ÀÀé½Õ¡¤Â¼Åľϡ¤ã·Æ£¼ë¼Â¡¤ÌÚ²¼Íøɧ ; À®¿Í·¿°ÛÀ÷À­Çò¼Á¥¸¥¹¥È¥í¥Õ¥£¡¼¤Î1Ʊ˦Îã²èÁü½ê¸«¤ÈÎ×¾²¾É¾õ¤Ë¤Ä¤¤¤Æ¡¥Àº¿À¿À·Ð³Ø»¨»ï102(4)399-409
  6. ±ä¸¶·òÆó¡¤×¢ÅÄÂîÌ顤¿ù»³Í´Éס¤ÌÚ²¼Íøɧ ; Àº¿À²Ê¼À´µ¤Ë¤ª¤±¤ëǾÇȤÎÎ×¾²¸¡ººË¡¤È¤·¤Æ¤ÎÍ­ÍÑÀ­¡¥ºÇ¿·Àº¿À°å³Ø 5(3): 283-288
  7. Ä«°æ ÃÎ ; ¥·¥ç¥¹¥¿¥³¡¼¥ô¥£¥Á¸¹³Ú»Í½ÅÁնʣ¸ÈÖ¡½¼«ÅÁŪºîÉʤˤߤëÆâ¤Ê¤ë¥Æ¥í¥ë¡½¡¥
    ÆüËÜÉÂÀ׳ػ¨»ï59 99-102
  8. ²­°æ ͵¡¤²ÏËÜ·½»Ê¡¤ÀÖº¬ ÆØ¡¤¶¶Ëܹ°ì¡¤ÌÚ²¼Íøɧ¡¤´äÀ¥Àµ¸²¡¤¿ÀÖ¿À¶°ìϺ¡¤°Â°æµ×Èþ»Ò¡¤ÃæëÔèÃË ; ǾÇȼ«Æ°²òÀÏ¥·¥¹¥Æ¥à¤Ë¤è¤ëǾ»àȽÄê¤Ø¤Î±þÍÑ¡¥Neurosurgical Emergency5(1)20-24
  9. ÌÚ²¼Íøɧ¡¢¿¥ÅÄ͵¹Ô ; À­Æ±°ìÀ­¾ã³²¡¥junior398¡§9-13

¥Ú¡¼¥¸TOP¤ØÌá¤ë

ÁíÀ⡦²òÀâ

  1. ÂçÌð Âç ; ²òÎ¥À­¾ã³²¡Ý¤½¤ÎÉ°ø¤ÈÉÂÂÖ¤ò¤á¤°¤Ã¤Æ¡¥¥×¥·¥³¥Õ¥£¥ê¥¢¸¦µæ1 :25-38,
  2. °ÂÊݲíÇ±ä¸¶·òÆó¡¤ Jorgen Borg¡¤ÊÆËܶ³»°¡¤µÜÌǯ ; ¥¹¥¦¥§¡¼¥Ç¥ó¤Î¹âÎð¼ÔÊ¡»ã­¡ ¹âÊ¡»ã¹ñ¥¹¥¦¥§¡¼¥Ç¥ó¤Ë»ê¤ëÎò»ËŪÇØ·Ê¡¥Journal of Clinical Rehabilitation(Î×¾²¥ê¥Ï)9(4): 408-412
  3. °ÂÊݲíÇ±ä¸¶·òÆó¡¤Jorgen Borg¡¤ÊÆËܶ³»°¡¤µÜÌǯ ; ¥¹¥¦¥§¡¼¥Ç¥ó¤Î¹âÎð¼ÔÊ¡»ã­¢¥¹¥¦¥§¡¼¥Ç¥ó¤ÎÏ·¿Í¥Û¡¼¥à¡¥Journal of Clinical Rehabilitation(Î×¾²¥ê¥Ï)9(5): 510-515
  4. °ÂÊݲíÇ±ä¸¶·òÆó¡¤Jorgen Borg¡¤ÊÆËܶ³»°¡¤µÜÌǯ ; ¥¹¥¦¥§¡¼¥Ç¥ó¤Î¹âÎð¼ÔÊ¡»ã­£ ºßÂ𥱥¢¡¥Journal of Clinical Rehabilitation(Î×¾²¥ê¥Ï)9(6): 630-634
  5. µÈ¼¶©»Ë¡¤ÌÚ²¼Íøɧ ; ²èÁü¾å¿ȯÀ­Ç¾¹¼ºÉ¤òǧ¤á,ÃÔÊò¾É¾õ¤òȼ¤¦ÍÞݵ¾õÂÖ¤ËÂФ·¥¢¥Ë¥é¥»¥¿¥à¤¬Ãø¸ú¤·¤¿1¾ÉÎã¡¥°åÌô¥¸¥ã¡¼¥Ê¥ë36(5)1431-1433
  6. ±ÊÅÄÀµ¹°¡¤ÌÚ²¼Íøɧ ; ­¸¹³ÉÔ°ÂÌô ¿·¤·¤¤¹³ÉÔ°ÂÌô¡¥Pharma Medical18(7)55-60

¥Ú¡¼¥¸TOP¤ØÌá¤ë

Ãø½ñ

  1. »³¸ýÀ®ÎÉ¡¤ÂçÌð Â硤ÈôÄ»°æ ˾¡¤µíÅçÄê¿® ; Àº¿À¾ã³²¤Ë¤ª¤±¤ë¿´°ø¡¥¿´°øÀ­¤ÈÀº¿À²ÊÎ×¾²Àº¿À²Ê¥ì¥Ó¥å¡¼ No.33 pp93-108 ¥é¥¤¥Õ¡¦¥µ¥¤¥¨¥ó¥¹
  2. °ëë½ÓÌÀ¡¤ÌÚ²¼Íøɧ ; ³°²Ê¤Ë¤ª¤±¤ëÀº¿À²ÊŪÌäÂ꡽A.¼ê½Ñ¤ÈÀº¿À¾ã³². Î×¾²Àº¿À°å³Ø¹ÖºÂ S7´¬ Áí¹ç¿ÇÎŤˤª¤±¤ëÀº¿À°å³Ø pp287-292, ¾¾²¼ÀµÌÀ,»°¹¥¸ùÊö ¾(ÊÔ)Ã滳½ñŹ
  3. ÌÚ²¼Íøɧ¡¤ã·Æ£Ä¾Ì¦¡¤Å£È´ÍøÌÀ ; Â裴¾ÏǾÇȲòÀÏË¡¤ÎÍýÏÀ¤ÈÎ×¾²±þÍÑ8.FFT dipole approximationË¡¡¥Î×¾²Ç¾ÇȤÈǾÇȲòÀÏpp118-125
  4. ÌøÀ¸Î´»ë¡¤ã·Æ£Ä¾Ì¦¡¤×¢ÅÄÂîÌ顤ÌÚ²¼Íøɧ ; Â裴¾ÏǾÇȲòÀÏË¡¤ÎÍýÏÀ¤ÈÎ×¾²±þÍÑ9.Adaptive Microstate Segmentation¤È LORETA¡¥Î×¾²Ç¾ÇȤÈǾÇȲòÀÏpp126-137

¥Ú¡¼¥¸TOP¤ØÌá¤ë